Minimum age of 11 set for UK puberty blocker trial
Gender-questioning children will have to be at least 11 years old to take part in a clinical trial of puberty-blocking drugs.
Professor of Health Care Law at UCL, Prof Sir Jonathan Montgomery, said: “Legal proceedings are expected to provide further scrutiny” of the trial, adding: “If there are legal issues that the regulators have overlooked, then it is in everyone’s interests that these are clarified as soon as possible.”
